secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0001193125-25-135949
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Verrica stockholders elect three directors, approve reverse split authorization at annual meeting
--------------------------------------------------------------------------------

- Elected directors Sean Stalfort (60.3M for), Diem Nguyen (58.8M for), Gavin Corcoran (63.0M for).
- Advisory vote on named executive officer compensation approved: 62.4M for, 1.3M against.
- Ratification of KPMG LLP as auditor for FY2025 approved: 81.9M for, 1.5M against.
- Approved reverse stock split authorization at ratio of 1-for-10 to 1-for-30, board discretion.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312525135949/0001193125-25-135949-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312525135949/d82912d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-135949

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer